4.7 Review

Laboratory Diagnosis of Infective Endocarditis

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 55, 期 9, 页码 2599-2608

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00635-17

关键词

clinical microbiology; endocarditis

资金

  1. BioFire
  2. Check-Points
  3. Curetis
  4. 3M
  5. Merck
  6. Hutchison Biofilm Medical Solutions
  7. Accelerate Diagnostics
  8. Allergan
  9. The Medicines Company
  10. ASM
  11. IDSA
  12. Samsung

向作者/读者索取更多资源

Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据